Cirex Pharmaceuticals Private Limited, a active private limited company, was established on 21 December 1990 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239TG1990PTC012119. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹4.15 Cr.
Formerly known as Cirex Pharmaceuticals Limited, Scirex Pharmaceuticals Limited. It upholds a compliant status. Its leadership includes Navin Kumar Reddy Puchakayala (Director), Chandra Sekhar Tumuluru (Director). Past directors included Viswanadha Raju Penmatsa, Bandi Vamsikrishna, Navin Kumar Reddy Puchakayala. It holds no open charges and ₹109.73 Cr settled loans. Its latest AGM occurred on 09 September 2024, with the balance sheet filed on 31 March 2024. It is based at H.No. 8-3-166/7/1, Erragadda, Hyderabad, Telangana, 500018.
U24239TG1990PTC012119
012119
21 December 1990
₹5.00 Cr
₹4.15 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Cirex Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Navin Kumar Reddy Puchakayala | Director | 17 Jun 2021 | Current |
| Chandra Sekhar Tumuluru | Director | 14 Jul 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Apr 2009 | Past |
| Pramod Abcsdd | Director | 29 Sep 2011 | Past |
| Pramod Abcsdd | Additional Director | 29 Nov 2021 | Past |
| Pramod Abcsdd | Additional Director | 17 Sep 2015 | Past |
| Pramod Abcsdd | Director | 31 Mar 2014 | Past |
| Pramod Abcsdd | Director | 22 Sep 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cirex Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 95.53% decrease. The company also saw a substantial fall in profitability, with a 81.36% decrease in profit. The company's net worth moved up by a moderate rise of 0.75%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Cirex Pharmaceuticals had a promoter holding of 95.86% and a public holding of 4.14%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹1,097,300,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 May 2009 | State Bank Of Hyderabad | ₹74.00 Cr | Satisfied |
| 09 Feb 2001 | State Bank Of Hyderabad | ₹34.50 Cr | Satisfied |
| 29 Mar 1995 | Indian Overseas Bank | ₹0.50 M | Satisfied |
| 20 Mar 1995 | Ap State Financial Corporation | ₹5.58 M | Satisfied |
| 22 Mar 1991 | Andhra Pradesh State Financial Corporation | ₹6.22 M | Satisfied |
Explore comprehensive loan charge details -
Cirex Pharmaceuticals has a workforce of 0 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Cirex Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cirex Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Cirex Pharmaceuticals Private Limited last Annual general meeting of members was held on 09 Sep 2024 as per latest MCA records. was completed.
Progress on Cirex Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
Progress on Navin Kumar Reddy Puchakayala was appointed as a Director was appointed as a Director on 17 Jun 2021 & has been associated with this company since 4 years 5 months . was documented.
A charge registered on 21 May 2009 via Charge ID 10163194 with State Bank Of Hyderabad was fully satisfied on 03 Dec 2015. was recorded as a recent event.
Progress on A charge registered on 09 Feb 2001 via Charge ID 90124225 with State Bank Of Hyderabad was fully satisfied on 03 Dec 2015. was documented.
Chandra Sekhar Tumuluru was appointed as a Director was appointed as a Director on 14 Jul 2015 & has been associated with this company since 10 years 4 months . was recorded as a recent event.
The CIN of Cirex Pharmaceuticals Private Limited is U24239TG1990PTC012119.
Cirex Pharmaceuticals Private Limited is headquartered at H.No. 8-3-166/7/1, Erragadda, Hyderabad, Telangana, 500018.
Cirex Pharmaceuticals Private Limited was incorporated on 21 December 1990.
The current directors of Cirex Pharmaceuticals Private Limited are
The primary industry of Cirex Pharmaceuticals Private Limited is Manufacturing.
Cirex Pharmaceuticals Private Limited is unlisted.
The authorized capital of Cirex Pharmaceuticals Private Limited is ₹5.00 Cr, and the paid-up capital is ₹4.15 Cr.
The compliance status of Cirex Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX